The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 7,670 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
ACCELERON PHARMA INC | COM | 00434H108 | 2,735 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
ACORDA THERAPEUTICS INC | COM | 00484M106 | 7,880 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 5,140 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 2,863 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 12,167 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 5,475 | 45,000 | SH | Call | SOLE | 45,000 | 0 | 0 | |
AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 4,221 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 4,163 | 196,287 | SH | SOLE | 196,287 | 0 | 0 | ||
ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 4,900 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
AUDENTES THERAPEUTICS INC | COM | 05070R104 | 957 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
AVEXIS INC | COM | 05366U100 | 15,610 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
AXOVANT SCIENCES LTD | COM | G0750W104 | 4,058 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 3,753 | 675,000 | SH | SOLE | 675,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 3,547 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 4,851 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 16,746 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
CLOVIS ONCOLOGY INC | COM | 189464100 | 28,183 | 301,000 | SH | Call | SOLE | 301,000 | 0 | 0 | |
CURRENCYSHS BRIT POUND STER | BRIT POUND STE | 23129S106 | 6,455 | 50,900 | SH | SOLE | 50,900 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 3,744 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 15,177 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 7,196 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ENDO INTL PLC | SHS | G30401106 | 8,378 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
ENTELLUS MED INC | COM | 29363K105 | 6,210 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 2,265 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 7,389 | 300,000 | SH | Put | SOLE | 300,000 | 0 | 0 | |
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 580 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
GENMARK DIAGNOSTICS INC | COM | 372309104 | 9,760 | 825,000 | SH | SOLE | 825,000 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 5,309 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
GW PHARMACEUTICALS PLC | ADS | 36197T103 | 12,531 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 10,596 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 8,151 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | ||
INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 2,484 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 6,210 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 4,043 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 6,374 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
IRIDEX CORP | COM | 462684101 | 2,473 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
JUNO THERAPEUTICS INC | COM | 48205A109 | 8,220 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
K2M GROUP HLDGS INC | COM | 48273J107 | 3,654 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
KITE PHARMA INC | COM | 49803L109 | 5,184 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
MERCK & CO INC | COM | 58933Y105 | 12,818 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 5,789 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
NEOS THERAPEUTICS INC | COM | 64052L106 | 3,650 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 6,900 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 12,281 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
NOVADAQ TECHNOLOGIES INC | COM | 66987G102 | 5,860 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
NUVASIVE INC | COM | 670704105 | 7,692 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
NXSTAGE MEDICAL INC | COM | 67072V103 | 6,518 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
PORTOLA PHARMACEUTICALS INC | COM | 737010108 | 11,234 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
PORTOLA PHARMACEUTICALS INC | COM | 737010108 | 22,468 | 400,000 | SH | Put | SOLE | 400,000 | 0 | 0 | |
PTC THERAPEUTICS INC | COM | 69366J200 | 3,666 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 13,110 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
QUOTIENT LTD | SHS | G73268107 | 2,208 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
RA PHARMACEUTICALS INC | COM | 74933V108 | 1,593 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
REVANCE THERAPEUTICS INC | COM | 761330109 | 2,357 | 89,295 | SH | SOLE | 89,295 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 3,003 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 3,982 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SEATTLE GENETICS INC | COM | 812578102 | 15,522 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
SPARK THERAPEUTICS INC | COM | 84652J103 | 2,091 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 27,013 | 350,000 | SH | Put | SOLE | 350,000 | 0 | 0 | |
SPECTRANETICS CORP | COM | 84760C107 | 7,680 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 2,794 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 6,993 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
VIEWRAY INC | COM | 92672L107 | 4,853 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
ZIMMER BIOMET HLDGS INC | COM | 98956P102 | 10,272 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 1,450 | 100,000 | SH | SOLE | 100,000 | 0 | 0 |